Related Experiment Video

Updated: Aug 24, 2026

Rapid Quantification of Oxidized and Reduced Forms of Glutathione Using Ortho -phthalaldehyde in Cultured Mammalian Cells In Vitro
03:35

Rapid Quantification of Oxidized and Reduced Forms of Glutathione Using Ortho -phthalaldehyde in Cultured Mammalian Cells In Vitro

Published on: June 28, 2024

Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein

P Christian Schulze1, Jun Yoshioka, Tomosaburo Takahashi

  • 1Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02139, USA.

The Journal of Biological Chemistry
|May 7, 2004
PubMed

Insights

Hyperglycemia impairs the thioredoxin antioxidant system by increasing Txnip, leading to oxidative stress in diabetes. Restoring thioredoxin activity may combat vascular complications.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Vascular Biology

Background:

  • Oxidative stress, driven by reactive oxygen species (ROS), contributes to vascular disease and diabetes complications.
  • The thioredoxin system is a key antioxidant mechanism for cellular redox balance, but its role in hyperglycemia is not fully understood.
  • Thioredoxin-interacting protein (Txnip) is an endogenous inhibitor of thioredoxin.

Purpose of the Study:

  • To investigate the mechanism by which hyperglycemia impairs the thioredoxin antioxidant system.
  • To determine the role of Txnip in hyperglycemia-induced oxidative stress in the vasculature.

Main Methods:

  • Studied the effect of hyperglycemia on thioredoxin function and Txnip expression in cell cultures and diabetic animal models.
  • Utilized p38 MAPK pathway inhibitors and Txnip gene silencing/overexpression techniques.
  • Assessed ROS levels, thioredoxin activity, and Txnip expression in vascular tissues.

Main Results:

  • Hyperglycemia inhibits thioredoxin's ROS-scavenging function via p38 MAPK-induced Txnip.
  • Overexpressing Txnip exacerbates oxidative stress, while Txnip gene silencing restores thioredoxin activity under hyperglycemia.
  • Diabetic animals showed increased vascular Txnip and reduced thioredoxin activity, which improved with insulin treatment.

Conclusions:

  • Hyperglycemia impairs the thioredoxin antioxidant system through Txnip induction.
  • Reduced thioredoxin activity due to Txnip interaction is a significant mechanism for vascular oxidative stress in diabetes.
  • Targeting the Txnip-thioredoxin interaction could be a therapeutic strategy for diabetic vascular complications.

More Related Videos

Induction and Analysis of Oxidative Stress in Sleeping Beauty Transposon-Transfected Human Retinal Pigment Epithelial Cells10:00

Induction and Analysis of Oxidative Stress in Sleeping Beauty Transposon-Transfected Human Retinal Pigment Epithelial Cells

Published on: December 11, 2020

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...